- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
TherapeuticsMD (TXMD)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.75 mm | 5.75 mm | 5.75 mm | 5.75 mm | 5.75 mm | 5.75 mm |
Cash burn (monthly) | (no burn) | (no burn) | 290.33 k | 374.08 k | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 813.17 k | 1.05 mm | n/a | n/a |
Cash remaining | n/a | n/a | 4.93 mm | 4.70 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | 17.0 | 12.6 | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 42 |
Opened positions | 7 |
Closed positions | 4 |
Increased positions | 4 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 3.06 bn |
Total shares | 35.55 mm |
Total puts | 4.40 k |
Total calls | 16.40 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 20.66 mm | $23.14 mm |
Smith Robert J | 11.35 mm | $0.00 |
Rubric Capital Management | 1.19 mm | $1.03 bn |
Clearline Capital | 635.22 k | $546.29 mm |
Tejara Capital | 394.66 k | $339.41 mm |
Vanguard | 387.58 k | $333.32 mm |
ADAR1 Capital Management | 270.16 k | $232.34 mm |
Citadel Advisors | 145.80 k | $125.40 mm |
MS Morgan Stanley | 132.39 k | $113.86 mm |
BlackRock | 116.13 k | $99.87 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Apr 25 | Marlan D Walker | Common Stock | Buy | Acquire P | No | No | 0.9985 | 490 | 489.27 | 73,639 |
14 Apr 25 | Tommy G Thompson | Common Stock | Buy | Acquire P | No | No | 1.0018 | 325 | 325.58 | 14,779 |
10 Apr 25 | Marlan D Walker | Common Stock | Buy | Acquire P | No | No | 0.8572 | 1,167 | 1.00 k | 73,149 |
9 Apr 25 | Marlan D Walker | Common Stock | Buy | Acquire P | No | No | 0.8747 | 1,136 | 993.66 | 71,982 |
18 Feb 25 | Tommy G Thompson | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,500 | 0.00 | 14,454 |
18 Feb 25 | Tommy G Thompson | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,500 | 0.00 | 0 |
18 Feb 25 | Marlan D Walker | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,733 | 0.00 | 70,846 |
18 Feb 25 | Marlan D Walker | Common Stock | Option exercise | Acquire M | No | No | 0 | 770 | 0.00 | 69,113 |
18 Feb 25 | Marlan D Walker | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,311 | 0.00 | 68,343 |
18 Feb 25 | Marlan D Walker | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,467 | 0.00 | 66,032 |